The PLATINO study: description of the distribution, stability, and mortality according to the Global Initiative for Chronic Obstructive Lung Disease classification from 2007 to 2017

References

• Global Strategy for the Diagnosis, Management and prevention of Chronic, Obstructive Pulmonary Disease, 2017 Report2016 [cited November, 2016]. Available from: http://goldcopd.org/Accessed February 27, 2017
   Google Scholar
• RabeKFHurdSAnzuetoAGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2007176653255517507545
   PubMed Web of Science ®Google Scholar
• ManninoDMThornDSwensenAHolguinFPrevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPDEur Respir J200832496296918579551
   PubMed Web of Science ®Google Scholar
• SpruitMAPolkeyMICelliBPredicting outcomes from 6-minute walk distance in chronic obstructive pulmonary diseaseJ Am Med Dir Assoc201213329129721778120
   PubMed Web of Science ®Google Scholar
• HoggJCChuFUtokaparchSThe nature of small-airway obstruction in chronic obstructive pulmonary diseaseN Engl J Med2004350262645265315215480
   PubMed Web of Science ®Google Scholar
• VestboJHurdSSAgustiAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
   PubMed Web of Science ®Google Scholar
• GoossensLMLeimerIMetzdorfNBeckerKRutten-van MolkenMPDoes the 2013 GOLD classification improve the ability to predict lung function decline, exacerbations and mortality: a post-hoc analysis of the 4-year UPLIFT trialBMC Pulm Med20141416325326750
   PubMed Web of Science ®Google Scholar
• SorianoJBAlfagemeIAlmagroPDistribution and prognostic validity of the new Global Initiative for Chronic Obstructive Lung Disease grading classificationChest2013143369470223187891
   PubMed Web of Science ®Google Scholar
• LangePMarottJLVestboJPrediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general populationAm J Respir Crit Care Med20121861097598122997207
   PubMed Web of Science ®Google Scholar
• HanMKMuellerovaHCurran-EverettDGOLD 2011 disease severity classification in COPDGene: a prospective cohort studyLancet Respir Med201311435024321803
   PubMed Web of Science ®Google Scholar
• AgustiAEdwardsLDCelliBCharacteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohortEur Respir J201342363664623766334
   PubMed Web of Science ®Google Scholar
• Montes de OcaMLópez VarelaMVLaucho-ContrerasMEClasificación de los pacientes con enfermedad pulmonar obstructiva crónica según los sistemas de estadificación de la Asociación Latino-americana de Tórax (ALAT) y la iniciativa global para la enfermedad pulmonar obstructiva crónica (GOLD) [Classification of patients with chronic obstructive pulmonary disease according to the Latin American Thoracic Association (ALAT) staging systems and the global initiative for chronic obstructive pulmonary disease (GOLD)]Arch Bronconeu-mol201753398106 English, Spanish
   Google Scholar
• MenezesAMPerez-PadillaRJardimJRChronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence studyLancet200536695001875188116310554
   PubMed Web of Science ®Google Scholar
• MenezesAMVictoraCGPerez-PadillaRPLATINO TeamThe Platino project: methodology of a multicenter prevalence survey of chronic obstructive pulmonary disease in major Latin American citiesBMC Med Res Methodol200441515202950
   PubMedGoogle Scholar
• MenezesAMMuinoALopez-VarelaMVEstudio de cohorte de base poblacional sobre la enfermedad pulmonarobstructiva crónica en Latinoamérica: métodos y resultados preliminares. Fase II del estudio PLATINO [A population-based cohort study on chronic obstructive pulmonary disease in Latin America: methods and preliminary results. The PLATINO Study Phase II]Arch Bronconeumol20145011017 English, Spanish24332830
   PubMed Web of Science ®Google Scholar
• The PLATINO Study [homepage on the Internet]Associacion Latino Americana del Tórax2011 Available from: www.platino-alat.org/datasets.htmlAccessed May 3, 2017
   Google Scholar
• FerrisBGEpidemiology standardization project (American Thoracic Society)Am Rev Respir Dis19781181120
   PubMed Web of Science ®Google Scholar
• European Community Respiratory Health Survey II Steering CommitteeThe European Community Respiratory Health Survey IIEur Respir J2002201071107912449157
   PubMed Web of Science ®Google Scholar
• BC Cancer Research CentreLung Health Study QuestionnaireVancouverBC Cancer Research Centre2004
   Google Scholar
• No authors listedStandardization of Spirometry, 1994 Update. American Thoracic SocietyAm J Respir Crit Care Med19951523110711367663792
   PubMed Web of Science ®Google Scholar
• Perez-PadillaRValdiviaGMuinoAValores de referencia espriométrica en 5 grandes ciudades de Latinoamérica para sujetos de 40 anos o más años de edad. [Spirometric reference values in 5 large Latin American cities for subjects aged 40 years or over]Arch Bronconeumol2006427317325 Spanish16945261
   PubMed Web of Science ®Google Scholar
• MenezesAMPerez-PadillaRWehrmeisterFCFEV1 is a better predictor of mortality than FVC: the PLATINO cohort studyPLoS One2014910e10973225285441
   PubMed Web of Science ®Google Scholar
• Perez-PadillaRWehrmeisterFCMontes de OcaMInstability in the COPD diagnosis upon repeat testing vary with the definition of COPDPLoS One2015103e012183225811461
   PubMed Web of Science ®Google Scholar
• VollmerWMGislasonTBurneyPComparison of spirometry criteria for the diagnosis of COPD: results from the BOLD studyEur Respir J200934358859719460786
   PubMed Web of Science ®Google Scholar
• Montes de OcaMTalamoCHalbertRJHealth status perception and airflow obstruction in five Latin American cities: the PLATINO studyRespir Med200910391376138219364640
   PubMed Web of Science ®Google Scholar
• HnizdoEGlindmeyerHWPetsonkELEnrightPBuistASCase definitions for chronic obstructive pulmonary diseaseCOPD2006329510017175672
   PubMedGoogle Scholar
• HardieJABuistASVollmerWMEllingsenIBakkePSMorkveORisk of over-diagnosis of COPD in asymptomatic elderly never-smokersEur Respir J20022051117112212449163
   PubMed Web of Science ®Google Scholar
• van DijkWTanWLiPClinical relevance of fixed ratio vs lower limit of normal of FEV1/FVC in COPD: patient-reported outcomes from the CanCOLD cohortAnn Fam Med2015131414825583891
   PubMed Web of Science ®Google Scholar
• GuderGBrennerSAngermannCEGOLD or lower limit of normal definition? A comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort-studyRespir Res20121311322309369
   PubMed Web of Science ®Google Scholar
• World Health OrganizationGlobal Action Plan for the Prevention and Control of Noncommunicable Diseases 2013–20202013 [cited November, 2016]. Available from: http://www.who.int/Accessed February 27, 2017
   Google Scholar
• World Health OrganizationModel List of Essential Medicines [cited April 2015]. Available from: http://www.who.int/medicines/publications/essentialmedicines/en/Accessed February 27, 2017
   Google Scholar